Responses
Inflammatory bowel disease
Original research
Distinct blood protein profiles associated with the risk of short-term and mid/long-term clinical relapse in patients with Crohn’s disease stopping infliximab: when the remission state hides different types of residual disease activity
Compose a Response to This Article
Other responses
No responses have been published for this article.